We are live on ! Find out more

1,621 hedge funds and large institutions have $127B invested in Merck in 2014 Q2 according to their latest regulatory filings, with 86 funds opening new positions, 615 increasing their positions, 679 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 58

13% more call options, than puts

Call options by funds: $849M | Put options by funds: $749M

1% more funds holding

Funds holding: 1,6021,621 (+19)

2% more capital invested

Capital invested by funds: $125B → $127B (+$2.09B)

0.29% more ownership

Funds ownership: 77.96%78.25% (+0.29%)

9% less repeat investments, than reductions

Existing positions increased: 615 | Existing positions reduced: 679

5% less funds holding in top 10

Funds holding in top 10: 147140 (-7)

Holders
1,621
Holders Change
+19
Holders Change %
+1.19%
% of All Funds
46.57%
Holding in Top 10
140
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-4.76%
% of All Funds
4.02%
New
86
Increased
615
Reduced
679
Closed
58
Calls
$849M
Puts
$749M
Net Calls
+$101M
Net Calls Change
-$177M
Name Holding Trade Value Shares
Change
Change in
Stake
MCM
1351
McKinley Capital Management
Alaska
$457K -$149K -2,736 -25%
TA
1352
TBP Advisors
New York
$455K
BRM
1353
Boston Research & Management
Massachusetts
$454K
WA
1354
Waverly Advisors
Alabama
$452K -$3.98K -73 -0.9%
SC
1355
Savant Capital
Illinois
$449K
CPO
1356
Cerity Partners OCIO
New York
$445K -$53.1K -974 -11%
CL
1357
Croft-Leominster
Maryland
$444K -$13.6K -250 -3%
NC
1358
NewSquare Capital
Pennsylvania
$443K +$3.38K +62 +0.8%
SEC
1359
Seven Eight Capital
New York
$439K +$433K +7,946 New
ZAM
1360
Zevin Asset Management
Massachusetts
$436K
AAP
1361
Ardsley Advisory Partners
Connecticut
$434K
NES
1362
New England Securities
New York
$434K +$144K +2,636 +50%
RB
1363
Rodgers Brothers
Pennsylvania
$433K
AB
1364
Atlas Brown
Kentucky
$432K +$89.3K +1,637 +26%
UR
1365
USCA RIA
Texas
$429K -$714K -13,083 -63%
BSB
1366
Bangor Savings Bank
Maine
$426K +$11.6K +213 +3%
AC
1367
Alexandria Capital
Virginia
$425K -$34.6K -634 -8%
DMC
1368
Drexel Morgan & Co
Pennsylvania
$421K
WCM
1369
Windsor Capital Management
Arizona
$421K +$24.8K +455 +6%
CCT
1370
Capital City Trust
Florida
$418K -$295K -5,413 -42%
PAS
1371
Professional Advisory Services
Florida
$418K
ZCA
1372
Zeke Capital Advisors
Pennsylvania
$418K +$7.58K +139 +2%
TAM
1373
Taurus Asset Management
New York
$417K -$165K -3,022 -29%
AIA
1374
Arbor Investment Advisors
North Carolina
$416K
FIB
1375
First Interstate Bank
Montana
$414K +$9K +165 +2%

MRK Hedge Fund Activity: Q2 2014 in Review

1,621 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2014, worth a combined $127B — up 1.7% from $125B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new MRK positions and 58 closed out — a net gain of 28 holders — while 615 added to existing stakes and 679 trimmed.

The largest buyer was Norges Bank, adding an estimated $1.27B. The largest seller was Fidelity Investments, cutting an estimated $623M.

  • 1,621 institutional investors held Merck (MRK) as of Q2 2014, up from 1,602 in Q1 2014.
  • Funds reported $127B of Merck stock for Q2 2014, up 1.7% quarter-over-quarter.
  • 86 funds opened new Merck positions in Q2 2014 and 58 closed out, a net change of +28 holders.
  • The largest Merck buyer in Q2 2014 was Norges Bank, an estimated $1.27B added.
  • The largest Merck seller in Q2 2014 was Fidelity Investments, an estimated $623M sold.

Based on aggregated 13F filings for Q2 2014.